|
|
|||||||
Case Reports |
Hematology-Oncology Unit, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Via Mariano Semmola, I-80131, Naples, Italy.
We report the results of treatment with single agent 2'-deoxycoformycin (Pentostatin) in two patients with Hepatosplenic gammadelta T-cell lymphoma (HSgammadeltaTCL), a rare lymphoma subtype with a highly unfavorable prognosis. Present and previous data reviewed here demonstrates the striking cytotoxic activity of Pentostatin against gammadelta+ tumor T cells. Further studies are warranted to define the optimal strategy to fully exploit therapeutic potential of this drug in patients with HSgammadeltaTCL.
This article has been cited by other articles:
![]() |
J. S. Abramson, C. N. Kotton, N. Elias, D. V. Sahani, and R. P. Hasserjian Case 8-2008 -- A 33-Year-Old Man with Fever, Abdominal Pain, and Pancytopenia after Renal Transplantation N. Engl. J. Med., March 13, 2008; 358(11): 1176 - 1187. [Full Text] [PDF] |
||||
![]() |
X Dray, F Joly, A Lavergne-Slove, X Treton, Y Bouhnik, and B Messing A severe but reversible refractory sprue. Gut, August 1, 2006; 55(8): 1210 - 1211. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |